Navigation Links
China BCT Reports Strong Second Quarter 2010 Results
Date:8/16/2010

or 2.5% of revenue, in the same period of 2009, primarily due to an increase in staff compensation and rental expense for newly opened stores and incremental public company professional fees. Selling expenses rose 31.6% to $1.1 million, compared to $0.8 million in the same period of 2009, due to the Company's increased sales and marketing activities.

Operating income increased 49.6% to $10.3 million, or 21.6% of revenue, from $6.9 million, or 20.6% of revenue, in the second quarter of 2009.

GAAP net income increased 35.3% to $7.1 million, or $0.19 per diluted share, as compared to $5.3 million, or $0.16 per diluted share, in the second quarter of 2009. Diluted earnings per share were calculated using weighted average shares of 38,471,274 and 32,000,000 for the quarters ended June 30, 2010 and June 30, 2009, respectively.

Adjusted net income, excluding the $0.4 million non-cash expense related to change in the fair value of warrant liabilities, was $7.6 million, or $0.20 per diluted share. There were no comparable adjustments to net income in the second quarter of 2009.

Six Months 2010 Results

Net revenue was $81.5 million in the first half of 2010, up 24.3% from $65.6 million in the first half of 2009. In terms of revenue mix, pharmacy distribution remained the Company's largest segment in first half 2010 at 69.4% of total sales, compared to 72.8% in the same period last year. Retail pharmacy represented 25.2% of total Company sales in first half 2010, up from 21.0% in the same period last year. Pharmacy manufacturing accounted for 5.4% of total sales during first half 2010, compared to 6.2% in the first half of last year.

Gross profit was $21.5 million, or 26.4% of revenue, up 23.7% from $17.4 million, or 26.5% of revenue, in the first half of 2009. Operating income was $16.5 million, or 20.2% of revenue, up 18.8% from $13.9 million, or 21.1% of revenue, in t
'/>"/>

SOURCE China BCT Pharmacy Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. China Biologic Products Announces Record Second Quarter 2010 Results
2. China Biologic Products to Attend Canaccord Genuity 30th Annual Growth Conference
3. China BCT Further Expands its Footprint by Opening 12 New Retail Pharmaceutical Stores
4. VIASPACE CEO Discusses Giant King Grass at Industrial Biotechnology Congress in China
5. Orchestrall Sponsors China Business Toolbox: Brings Focus to the How and When of China Market Access
6. China-Biotics to Report Fiscal Year 2011 First Quarter Financial Results on August 9
7. Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016
8. China Cord Blood Corporation Announces Cancellation of Nine Million Management Incentive Warrants
9. China-Biotics Provides Further Updates on Qingpu New Facility
10. United Therapeutics and Lees Pharmaceutical Sign Remodulin Distribution Agreement for China
11. China Agritech, Inc. Receives $10 Million From Warrant Exercise by The Carlyle Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Navitas, a leading Regulatory Service ... America hub in Bogota, Colombia . Navitas, ... the many benefits provided by Colombia , the third ... Logo - http://photos.prnewswire.com/prnh/20150703/228239LOGO ... location, allows US based clients to communicate with Navitas regulatory professionals in ...
(Date:7/5/2015)... ... July 06, 2015 , ... For many years, metal-on-quartz filters were the ... machine such as a Varian Cary 4000-7000, a Perkin Elmer 800-1100 or a Shimadzu ... even NIST used them for their SRM-2031 series going back for many years. Unfortunately, ...
(Date:7/3/2015)... 3, 2015 ... osoitteessa  http://www.openinnovationinscience.at Wienissä pidettävään ... Science" -jatkokoulutusohjelmaan 22.7.2015 asti.  ... tekemän, kansainvälisiä tutkijoita ja tiedemiehiä ... suurinta haastetta ovat kannustimien puute ...
(Date:7/3/2015)... ... 2015 , ... The global failure analysis market is expected to reach $7,147.0 ... market is expected to grow at the highest CAGR of 8.46%; its growth is ... research labs and academic institutions for root cause analysis of failure. The market based ...
Breaking Biology Technology:Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5
... Caliper Life Sciences, Inc. (NASDAQ: CALP ... drug discovery and life sciences research for personalized medicine, ... meeting on May 17th and 18th.  This annual event ... diagnostics to discuss the technologies and discoveries that are ...
... ROCKVILLE, Md., May 5, 2011 Vanda Pharmaceuticals Inc. ... focused on the development and commercialization of products for ... results for the first quarter ended March 31, 2011. ... progress we have made to date in 2011," said ...
... PASADENA, Calif., May 4, 2011 Highlights ... from Operations ("FFO") Per Share (Diluted) Attributable to Alexandria Real ... 2011 Losses on Early Extinguishment of Debt, Up 6% Compared ... First Quarter 2011 Earnings Per Share (Diluted) Attributable to ...
Cached Biology Technology:Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine 2Vanda Pharmaceuticals Reports First Quarter 2011 Results 2Vanda Pharmaceuticals Reports First Quarter 2011 Results 3Vanda Pharmaceuticals Reports First Quarter 2011 Results 4Vanda Pharmaceuticals Reports First Quarter 2011 Results 5Vanda Pharmaceuticals Reports First Quarter 2011 Results 6Vanda Pharmaceuticals Reports First Quarter 2011 Results 7Vanda Pharmaceuticals Reports First Quarter 2011 Results 8Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 2Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 3Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 4Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 5Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 6Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 7Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 8Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 9Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 10Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 11Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 12Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 13Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 14Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 15Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 16
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... has announced the addition of the "Natural ... Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... to their offering. The key vendors ... Google, HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/24/2015)... 2015 The biologics safety testing market is ... the market include growth of the pharmaceutical and biological ... Over the years, the number of drug approvals in ... the FDA approved 225 drug applications and Health Canada ... Europe accounted for 3,822 of the pharmaceutical ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... new study in mice, a scientific collaboration centered at ... signaling breakdown in Angelman syndrome, a disorder that affects ... seizures, and other problems. With the new understanding, the ... works to restore neural functions impaired by the disease. ...
... FRANCISCO February 12, 2013 New findings from a ... predict whether a person is likely to develop age-related macular ... than nine million Americans, these genes do not predict how ... most widely used to treat the "wet" form of AMD. ...
... New Geology science posted online ahead of ... several sites in the U.S., as well as work ... southeastern Pacific, South Africa, and Mars. Tectonics, flooding, carbon ... Brief highlights follow. Papers cover , 1. ...
Cached Biology News:Study in mice yields Angelman advance 2Study in mice yields Angelman advance 3Study in mice yields Angelman advance 4Major clinical trial finds no link between genetic risk factors and 2 top wet AMD treatments 2The Geological Society of America Journal Geology: Dynamic geoscience 2The Geological Society of America Journal Geology: Dynamic geoscience 3The Geological Society of America Journal Geology: Dynamic geoscience 4The Geological Society of America Journal Geology: Dynamic geoscience 5The Geological Society of America Journal Geology: Dynamic geoscience 6The Geological Society of America Journal Geology: Dynamic geoscience 7The Geological Society of America Journal Geology: Dynamic geoscience 8The Geological Society of America Journal Geology: Dynamic geoscience 9The Geological Society of America Journal Geology: Dynamic geoscience 10The Geological Society of America Journal Geology: Dynamic geoscience 11The Geological Society of America Journal Geology: Dynamic geoscience 12The Geological Society of America Journal Geology: Dynamic geoscience 13The Geological Society of America Journal Geology: Dynamic geoscience 14The Geological Society of America Journal Geology: Dynamic geoscience 15
... Each Signet Level 2 Detection ... the avidin-biotin chemical bonding principle and ... to provide sensitivity, specificity and reliablility. ... immunostaining in both manual and automated ...
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA ...
6X DNA Gel Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
Biology Products: